{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T18:47:56Z","timestamp":1788634076249,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Korea Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.174029","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T15:23:50Z","timestamp":1615649030000},"page":"174029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Antinociceptive effect of intrathecal P7C3 via GABA in a rat model of inflammatory pain"],"prefix":"10.1016","volume":"899","author":[{"given":"Sang Wan","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeo Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Byul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seog Bae","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Il","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Ha","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.174029_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1089\/neu.2013.3135","article-title":"Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury","volume":"31","author":"Blaya","year":"2014","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.ejphar.2021.174029_bib2","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.neuroscience.2006.05.048","article-title":"Secondary hyperalgesia in the monoarthritic rat is mediated by GABAB and NK1 receptors of spinal dorsal horn neurons: a behavior and c-fos study","volume":"141","author":"Castro","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174029_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/npjparkd.2015.10","article-title":"Protective efficacy of P7C3-S243 in the 6-hydroxydopamine model of Parkinson's disease","volume":"1","author":"De Jesus-Cortes","year":"2015","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ejphar.2021.174029_bib4","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease","volume":"109","author":"De Jesus-Cortes","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174029_bib5","doi-asserted-by":"crossref","first-page":"8330","DOI":"10.1167\/iovs.14-15468","article-title":"Early detection of subclinical visual damage after blast-mediated TBI enables prevention of chronic visual deficit by treatment with P7C3-S243","volume":"55","author":"Dutca","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejphar.2021.174029_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0361-9230(98)00159-2","article-title":"Transmitters involved in antinociception in the spinal cord","volume":"48","author":"Furst","year":"1999","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejphar.2021.174029_bib7","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3389\/fncel.2018.00400","article-title":"P7C3 inhibits LPS-induced microglial activation to protect dopaminergic neurons against inflammatory factor-induced cell death in vitro and in vivo","volume":"12","author":"Gu","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2021.174029_bib8","doi-asserted-by":"crossref","first-page":"e2858","DOI":"10.1038\/cddis.2017.250","article-title":"P7C3 inhibits GSK3beta activation to protect dopaminergic neurons against neurotoxin-induced cell death in vitro and in vivo","volume":"8","author":"Gu","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2021.174029_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11916-012-0260-4","article-title":"Spinal cord stimulation: neurophysiological and neurochemical mechanisms of action","volume":"16","author":"Guan","year":"2012","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejphar.2021.174029_bib10","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1097\/ALN.0b013e3181fcd95c","article-title":"Spinal cord stimulation-induced analgesia: electrical stimulation of dorsal column and dorsal roots attenuates dorsal horn neuronal excitability in neuropathic rats","volume":"113","author":"Guan","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2021.174029_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuroscience.2011.03.060","article-title":"Differential GABAergic disinhibition during the development of painful peripheral neuropathy","volume":"184","author":"Janssen","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174029_bib12","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1073\/pnas.0730698100","article-title":"Demonstration of functional coupling between gamma -aminobutyric acid (GABA) synthesis and vesicular GABA transport into synaptic vesicles","volume":"100","author":"Jin","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174029_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S0022-3565(24)36830-2","article-title":"Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat","volume":"282","author":"Kaneko","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2021.174029_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.neuroscience.2014.10.005","article-title":"Pharmacologic rescue of motor and sensory function by the neuroprotective compound P7C3 following neonatal nerve injury","volume":"284","author":"Kemp","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174029_bib15","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3565(25)32970-8","article-title":"Comparison of the antinociceptive effect of gamma-aminobutyric acid (GABA) agonists: evidence for a cholinergic involvement","volume":"220","author":"Kendall","year":"1982","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2021.174029_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0022-3565(25)30974-2","article-title":"The analgesic action of baclofen [beta-(4-chlorophenyl)-gamma-aminobutyric acid]","volume":"202","author":"Levy","year":"1977","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2021.174029_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.29626","article-title":"Pharmacological augmentation of nicotinamide phosphoribosyltransferase (NAMPT) protects against paclitaxel-induced peripheral neuropathy","volume":"6","author":"LoCoco","year":"2017","journal-title":"Elife"},{"key":"10.1016\/j.ejphar.2021.174029_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0306-4522(03)00174-X","article-title":"Distribution and colocalisation of glutamate decarboxylase isoforms in the rat spinal cord","volume":"119","author":"Mackie","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2021.174029_bib19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1021\/ja108211m","article-title":"Development of proneurogenic, neuroprotective small molecules","volume":"133","author":"MacMillan","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejphar.2021.174029_bib20","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000542-200205000-00020","article-title":"Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain","volume":"96","author":"Malan","year":"2002","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2021.174029_bib21","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0165-6147(96)01013-9","article-title":"GABA and its receptors in the spinal cord","volume":"17","author":"Malcangio","year":"1996","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2021.174029_bib22","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0028-3908(99)00121-5","article-title":"Nociceptive regulation of GABA(B) receptor gene expression in rat spinal cord","volume":"38","author":"McCarson","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174029_bib23","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/jm401919s","article-title":"Discovery of a neuroprotective chemical, (S)-N-(3-(3,6-dibromo-9H-carbazol-9-yl)-2-fluoropropyl)-6-methoxypyridin-2-amine [(-)-P7C3-S243], with improved druglike properties","volume":"57","author":"Naidoo","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2021.174029_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/npp.2013.221","article-title":"Antihyperalgesia by alpha2-GABAA receptors occurs via a genuine spinal action and does not involve supraspinal sites","volume":"39","author":"Paul","year":"2014","journal-title":"Neuropsychopharmacology : Off. Publ. Am. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ejphar.2021.174029_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1101\/sqb.2018.83.037622","article-title":"Benefits of enhancing nicotinamide adenine dinucleotide levels in damaged or diseased nerve cells","volume":"83","author":"Pieper","year":"2018","journal-title":"Cold Spring Harbor Symp. Quant. Biol."},{"key":"10.1016\/j.ejphar.2021.174029_bib26","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.06.018","article-title":"Discovery of a proneurogenic, neuroprotective chemical","volume":"142","author":"Pieper","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174029_bib27","first-page":"109","article-title":"Uniqueness and redundancy in GABA production","volume":"5","author":"Pinal","year":"1998","journal-title":"Perspect. Dev. Neurobiol."},{"key":"10.1016\/j.ejphar.2021.174029_bib28","doi-asserted-by":"crossref","first-page":"32544","DOI":"10.1074\/jbc.M109.040071","article-title":"Blocking L-type voltage-gated Ca2+ channels with dihydropyridines reduces gamma-aminobutyric acid type A receptor expression and synaptic inhibition","volume":"284","author":"Saliba","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2021.174029_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1124\/jpet.102.046342","article-title":"Differential regulation of GABA B receptor subunit expression and function","volume":"305","author":"Sands","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2021.174029_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0306-3623(96)00241-8","article-title":"Involvement of GABAB receptors in the antinociception induced by baclofen in the formalin test","volume":"28","author":"Shafizadeh","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.174029_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0028-3908(94)90149-X","article-title":"Increased sensitivity to the antinociceptive activity of (+\/-)-baclofen in an animal model of chronic neuropathic, but not chronic inflammatory hyperalgesia","volume":"33","author":"Smith","year":"1994","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174029_bib32","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00006123-199608000-00026","article-title":"Release of gamma-aminobutyric acid in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats","volume":"39","author":"Stiller","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ejphar.2021.174029_bib33","doi-asserted-by":"crossref","first-page":"17016","DOI":"10.1073\/pnas.1213960109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of amyotrophic lateral sclerosis","volume":"109","author":"Tesla","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejphar.2021.174029_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0006-8993(96)00100-X","article-title":"Antinociception produced by systemic R(+)-baclofen hydrochloride is attenuated by CGP 35348 administered to the spinal cord or ventromedial medulla of rats","volume":"718","author":"Thomas","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2021.174029_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0028-3908(85)90076-0","article-title":"A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen","volume":"24","author":"Vaught","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2021.174029_bib36","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopsych.2017.10.023","article-title":"(-)-P7C3-S243 protects a rat model of alzheimer's disease from neuropsychiatric deficits and neurodegeneration without altering amyloid deposition or reactive glia","volume":"84","author":"Voorhees","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.ejphar.2021.174029_bib37","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/mp.2014.34","article-title":"The P7C3 class of neuroprotective compounds exerts antidepressant efficacy in mice by increasing hippocampal neurogenesis","volume":"20","author":"Walker","year":"2015","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.ejphar.2021.174029_bib38","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cell.2014.07.040","article-title":"P7C3 neuroprotective chemicals function by activating the rate-limiting enzyme in NAD salvage","volume":"158","author":"Wang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2021.174029_bib39","series-title":"Preclinical Models of Nociception","first-page":"685","author":"Yaksh","year":"1997"},{"key":"10.1016\/j.ejphar.2021.174029_bib40","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0031-9384(76)90029-9","article-title":"Chronic catheterization of the spinal subarachnoid space","volume":"17","author":"Yaksh","year":"1976","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2021.174029_bib41","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.celrep.2014.08.030","article-title":"P7C3 neuroprotective chemicals block axonal degeneration and preserve function after traumatic brain injury","volume":"8","author":"Yin","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2021.174029_bib42","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00000542-200309000-00027","article-title":"Pharmacologic interaction between cannabinoid and either clonidine or neostigmine in the rat formalin test","volume":"99","author":"Yoon","year":"2003","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2021.174029_bib43","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1034\/j.1399-6576.2003.00212.x","article-title":"Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats","volume":"47","author":"Yoon","year":"2003","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ejphar.2021.174029_bib44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/0024-3205(85)90008-6","article-title":"GABA uptake inhibitors produce a greater antinociceptive response in the mouse tail-immersion assay than other types of GABAergic drugs","volume":"37","author":"Zorn","year":"1985","journal-title":"Life Sci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:38Z","timestamp":1757976518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":44,"alternative-id":["S0014299921001825"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174029","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive effect of intrathecal P7C3 via GABA in a rat model of inflammatory pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.174029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174029"}}